Wells Fargo & Company »

Serina Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Serina Therapeutics (SER) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Serina Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Serina Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Serina Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $13 2 6.50
2024-06-30 $19 2 9.50
2024-03-31 $783 58 13.50